Amber Implants
-
Spine
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix® Spinal System
THE HAGUE, Netherlands, June 11, 2024 /PRNewswire/ — Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants…
Read More » -
Spine
Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures THE HAGUE, Netherlands, Oct. 3, 2023 /PRNewswire/ — Amber Implants, an innovative medical…
Read More » -
Spine
Amber Implants receives approval for First in Human study in Europe
The Hague, Netherlands, June 6, 2023 /OrthoSpineNews/ – Amber Implants has achieved a significant milestone by obtaining regulatory approval for our…
Read More » -
Financial
Amber Implants Closes US$10 M Series A Financing
THE HAGUE, Netherlands, Jan. 19, 2022 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal…
Read More » -
Regulatory
Amber Implants VCFix® spinal system receives US FDA Breakthrough designation
HAGUE, Netherlands, Oct. 5, 2021 /PRNewswire/ — Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today…
Read More »